Sclerosis, Progressive Systemic Completed Phase 2 Trials for Treprostinil (DB00374)

Also known as: Sclerosis, Systemic / Systemic Sclerosis / Progressive systemic sclerosis / Scleroderma, Systemic / Scleroderma

IndicationStatusPhase
DBCOND0080156 (Sclerosis, Progressive Systemic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00775463Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil DiethanolamineTreatment
NCT02663895Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic SclerosisTreatment